Report copyright - Postępy w leczeniu raka nerki - Health Project Management · 2018. 6. 5. · Eur J Cancer 2014;50:1084–9. Sunitynib Pazopanib Bewacyzumab + IFN-α Temsyrolimus Dawka początkowa
Please pass captcha verification before submit form
Please pass captcha verification before submit form